a content greater than 1.5 C150 RF1 with a value of at least 3 times less than the hepatitis B surface antigen produced in presence of thiomersal.A method for producing an Antigen of hepatitis A vaccine suitable for use in the procedure, including the purification of the Antigen in the ...
Animal cell culture is an important technique used for the development of viral vaccine production. The technique has been used for the development of a recombinant vaccine against hepatitis B and poliovirus. Immortalized cell lines are used for the large-scale or industrial production of viral vacc...
Procedure for the preparation of an intravenous compatible vaccine against distemper and hepatitis contagious canis and which is free of adjuvants, characterized in that it combines: attenuated distemper viruses and inactivated viruses of hepatitis contagious canis, is eventually concentrated in a known ...
THE COMPOSITIONS OF ANTIBODY VACCINE AND EFFECTIVE ANTIGENS TO PREVENT INFECTION OF HEPATITIS VIRUSS (HEV) ARE DISCOVERED. THE ANTIGENIC COMPOSITION INCLUDES A PEPTIDE CORRESPONDING TO THE CARBOXYL-TERMINAL PROTEIN OF THE CAPSIDA CODIFIED BY THE SECOND OPEN READING PHASE (2) OF THE HEV GENOME. ...
PROCEDURE TO PURIFY HEPATITIS A VIRUS (HAV), THE SAID VIRUS PURIFIED AND VACCINE COMPOSITIONS THAT CONTAIN THEM.A PROCESS FOR THE PURIFICATION OF THE HEPATITIS VIRUS IS DESCRIBED (A) THAT ALLOWS TO OBTAIN WITH GOOD PERFORMANCE A PURE PRODUCT, IN WHICH THE ORGANIC MATERIAL COLLECTED THROUGH ...
Antigen and antibody vaccine composition effective in preventing hepatitis E virus (HEV) infection are disclosed. The antigen composition includes a peptide corresponding to a carboxyl terminal end region of the capsid protein encoded by the second open reading frame 2 of the HEV genome. The ...
PROCEDURE FOR THE PRODUCTION OF PLASMA, PLASMA PREPARATION AND VACCINE AGAINST HEPATITISHeat treatment of dry, for instance, lyophilized plasma compositions particularly fractions containing Factor VIII concentrates inactivates undesirable micro-organisms such as any hepatitis virus. Subsequent reconstitution is...
Antigen and antibody vaccine composition effective in preventing hepatitis E virus (HEV) infection are disclosed. The antigen composition includes a peptide corresponding to a carboxyl terminal end region of the capsid protein encoded by the second open reading frame 2 of the HEV genome. The ...
regulatory region sintetizad HBsAg Or by the expression of HBsAg is exempt from the sequence of amino acid residues foreign \\/ os.The recombinant DNA Molecule contains a sequence of nucleotides that can Encode the hepatitis B surface antigen (HBsAg) and so-called) that can be expressed in ...